Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1)
- PMID: 18094002
- PMCID: PMC2566534
- DOI: 10.1136/ard.2007.077537
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1)
Abstract
Objective: In the present work, we investigate the role of interleukin (IL)27/IL27 receptor alpha (Ralpha) (WSX-1) in the development of autoimmune disorders in the MRL/lpr mouse, which is considered as an experimental model of systemic lupus erythaematosus (SLE) in humans.
Methods: We generated two strains of WSX-1 transgenic mice in the MRL/lpr background with different expression levels of WSX-1, and investigated the effect of WSX-1 overexpression on survival, glomerulonephritis and immunological properties.
Results: In comparison with wild type (WT) MRL/lpr and transgenic (Tg) low (TgL) mice, Tg high (TgH) mice exhibited a prolonged lifespan and no apparent development of autoimmune nephritis. Production of anti-dsDNA antibody and total IgG and IgG2a were significantly lower in TgH mice than those of TgL and WT mice. The expressed amounts of interferon (IFN)gamma and IL4 mRNA by CD4+ T cells from Tg mice decreased in a dose-dependent fashion. CD4+ splenic lymphocytes in TgH mice were more subject to the IL27-mediated suppression of cytokine production. In vitro stimulation of CD4+ T cells by IL27 resulted in over phosphorylation of STAT3 in TgH cells than in WT cells.
Conclusion: WSX-1 overexpression in the MRL/lpr background rendered the autoimmune prone mice protected from the development of autoimmune diseases. Our results suggest that IL27 signalling may be a therapeutic target against autoimmune diseases, including human SLE.
Conflict of interest statement
Figures





Similar articles
-
Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells.Autoimmunity. 2013 Nov;46(7):446-54. doi: 10.3109/08916934.2013.809422. Epub 2013 Jul 11. Autoimmunity. 2013. PMID: 23845089
-
Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.Cell Immunol. 2001 Jun 15;210(2):77-86. doi: 10.1006/cimm.2001.1818. Cell Immunol. 2001. PMID: 11520074
-
Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1).J Immunol. 2005 Dec 1;175(11):7185-92. doi: 10.4049/jimmunol.175.11.7185. J Immunol. 2005. PMID: 16301622
-
Interleukin 21 as a target of intervention in autoimmune disease.Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii83-6. doi: 10.1136/ard.2008.098400. Ann Rheum Dis. 2008. PMID: 19022821 Review.
-
Cellular and molecular mechanisms of regulation of autoantibody production in lupus.Ann N Y Acad Sci. 2005 Jun;1051:433-41. doi: 10.1196/annals.1361.085. Ann N Y Acad Sci. 2005. PMID: 16126985 Free PMC article. Review.
Cited by
-
Keratoacanthoma accompanied by multiple lung squamous cell carcinomas developing in a renal transplant recipient.Case Rep Dermatol. 2014 Jul 9;6(2):169-75. doi: 10.1159/000365626. eCollection 2014 May. Case Rep Dermatol. 2014. PMID: 25120468 Free PMC article.
-
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. J Neurol Sci. 2013. PMID: 23578791 Free PMC article. Review.
-
Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.Cell Transplant. 2024 Jan-Dec;33:9636897241236586. doi: 10.1177/09636897241236586. Cell Transplant. 2024. PMID: 38469823 Free PMC article. Review.
-
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction.Nat Commun. 2015 Jan 23;6:6072. doi: 10.1038/ncomms7072. Nat Commun. 2015. PMID: 25614966 Free PMC article.
-
An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases.Front Immunol. 2024 Mar 19;15:1366377. doi: 10.3389/fimmu.2024.1366377. eCollection 2024. Front Immunol. 2024. PMID: 38566992 Free PMC article. Review.
References
-
- Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002;16:779–90 - PubMed
-
- Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003;170:4886–90 - PubMed
-
- Sprecher CA, Grant FJ, Baumgartner JW, Presnell SR, Schrader SK, Yamagiwa T, et al. Cloning and characterization of a novel class I cytokine receptor. Biochem Biophys Res Commun 1998;246:82–90 - PubMed
-
- Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004;172:2225–31 - PubMed
-
- Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000;407:916–20 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous